8-(TRIFLUOROMETHYL)-2,3-DIHYDROISOQUINOLIN-3-ONE, 95%, 1g

N-(3,4-Difluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity), 97%, 50mg

4-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxamide, 98%, 1g

2-Chloro-4-fluorophenylboronic acid, 96.0%, 5g

Dialysis membrane Spectra/Por® Biotech CE MWCO 100–500, 10 mm, 1 Piece(s)

2-(1-Methylguanidino)acetic acid, 98.0%, 100g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole, 95.0%, 250mg

2-(Methoxymethyl)pyrimidin-5-ol, 98%, 100mg

1-(4-Methoxy-pyridin-2-yl)-ethanol, 95.0%, 1g

(2,4-dichloro-3-methylphenyl)amine hydrochloride, 95.0%, 100mg

3-(5-(Methoxycarbonyl)-1H-pyrrol-2-yl)propanoic acid, 97%, 100mg

5H-Chromeno[2,3-b]pyridine, 98%, 100mg

Calcium hydroxide, 95.0%, 500g